Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Coronary Thrombosis D003328 7 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Cystitis D003556 23 associated lipids
Death, Sudden D003645 12 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Dictyocaulus Infections D004022 1 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Duodenal Ulcer D004381 12 associated lipids
Dyslexia D004410 3 associated lipids
Ear Diseases D004427 7 associated lipids
Edema D004487 152 associated lipids
Encephalitis D004660 15 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Arnoux B et al. Effect of PAF-acether in non-human primates. 1988 Prog. Clin. Biol. Res. pmid:2837781
Livio M et al. Role of platelet-activating factor in primary hemostasis. 1988 Am. J. Physiol. pmid:2837916
Hoffman DR et al. Synthesis of platelet activating factor by cholinephosphotransferase in developing fetal rabbit lung. 1988 Lipids pmid:2897059
Leff AR Neurohumoral regulation of airway contractile responses. 1988 Chest pmid:2897271
Junier MP et al. Inhibitory effect of platelet-activating factor (PAF) on luteinizing hormone-releasing hormone and somatostatin release from rat median eminence in vitro correlated with the characterization of specific PAF receptor sites in rat hypothalamus. 1988 Endocrinology pmid:2898362
Guinot P et al. Treatment of adult systemic mastocytosis with a PAF-acether antagonist BN52063. 1988 Lancet pmid:2898694
Michel L et al. Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin. 1988 J. Allergy Clin. Immunol. pmid:2899102
Michel L et al. Release of PAF-acether and precursors during allergic cutaneous reactions. 1988 Lancet pmid:2899817
Bachelet M et al. Interaction between PAF-acether and drugs that stimulate cyclic AMP in guinea-pig alveolar macrophages. 1988 Eur. J. Pharmacol. pmid:2840303
Martins MA et al. Intravenous injections of PAF-acether induce platelet aggregation in rats. 1988 Eur. J. Pharmacol. pmid:3135199
Peers SH Dexamethasone inhibits platelet activating factor-induced inflammation in the paw but not the pleural cavity of rats. 1988 Eur. J. Pharmacol. pmid:3136026
Mangold HK Synthesis of biologically active ether lipids. 1988 Prog Biochem Pharmacol pmid:3136454
Anderson GP et al. Increased airways responsiveness to histamine induced by platelet activating factor in the guinea-pig: possible role of lipoxygenase metabolites. 1988 Agents Actions pmid:3136622
Fernandez-Gallardo S et al. Role of paf-acether in the mediation of pathophysiological responses to aggregated immunoglobulins. Studies with the platelet-activating factor receptor antagonist BN 52021. 1988 Int. J. Immunopharmacol. pmid:3139574
Slapke J et al. [Test hierarchy for the development of new drug action principles with the action site in phospholipid metabolism for bronchial asthma and pulmonary hypertension]. 1988 Prax Klin Pneumol pmid:3140230
Ferrell JE et al. Membrane bilayer balance and platelet shape: morphological and biochemical responses to amphipathic compounds. 1988 Biochim. Biophys. Acta pmid:3355815
López-Farré A et al. Glomeruli from ischemic rat kidneys produce increased amounts of platelet activating factor. 1988 Biochem. Biophys. Res. Commun. pmid:3358756
Kuiper J et al. The induction of glycogenolysis in the perfused liver by platelet activating factor is mediated by prostaglandin D2 from Kupffer cells. 1988 Biochem. Biophys. Res. Commun. pmid:3144970
Berti F et al. New pharmacological data on the bronchospasmolytic activity of bamifylline. 1988 Arzneimittelforschung pmid:3365275
Sun XM and Hsueh W Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. 1988 J. Clin. Invest. pmid:3366898
Calignano A et al. Isolation and identification of platelet-activating factor in UV-irradiated guinea pig skin. 1988 J Pharmacol Methods pmid:3367652
Nolte D [Bronchial hyperreactivity: pingpong between cells, nerves and mediators]. 1988 Med. Klin. (Munich) pmid:3367876
Bratton DL et al. Effects of platelet activating factor and related lipids on phase transition of dipalmitoylphosphatidylcholine. 1988 Biochim. Biophys. Acta pmid:3370214
Wang J et al. The effects of endotoxin on platelet-activating factor synthesis in cultured rat glomerular mesangial cells. 1988 Biochim. Biophys. Acta pmid:3370222
Smith RJ et al. Diacylglycerols modulate human polymorphonuclear neutrophil responsiveness: effects on intracellular calcium mobilization, granule exocytosis, and superoxide anion production. 1988 J. Leukoc. Biol. pmid:2836539
Jouquey S et al. Comparison of the effects of the ace inhibitors trandolapril and enalapril on phlogogen induced foot pad oedema in the rat. 1988 Agents Actions pmid:2459935
Spinks NR and O'Neill C Antagonists of embryo-derived platelet-activating factor prevent implantation of mouse embryos. 1988 J. Reprod. Fertil. pmid:2460623
Dorsch W et al. Anti-asthmatic effects of onions. Alk(en)ylsulfinothioic acid alk(en)yl-esters inhibit histamine release, leukotriene and thromboxane biosynthesis in vitro and counteract PAF and allergen-induced bronchial obstruction in vivo. 1988 Biochem. Pharmacol. pmid:2462422
Serio R and Daniel EE Thromboxane effects on canine trachealis neuromuscular function. 1988 J. Appl. Physiol. pmid:2839451
Lagente V and Fortes ZB Role of PAF-acether in the vascular events of inflammation. 1988 Prog Biochem Pharmacol pmid:3043429
Cordeiro RS et al. Proinflammatory activity of platelet-activating factor: pharmacological modulation and cellular involvement. 1988 Prog Biochem Pharmacol pmid:3043430
Pirotzky E and Braquet P PAF-acether and kidney pathology. 1988 Prog Biochem Pharmacol pmid:3043431
Feuerstein G and Siren AL Platelet-activating factor and shock. 1988 Prog Biochem Pharmacol pmid:3043432
Godfroid JJ and Heymans F Chemistry of PAF antagonists. 1988 Prog Biochem Pharmacol pmid:3043433
Casals-Stenzel J and Heuer H Pharmacology of PAF antagonists. 1988 Prog Biochem Pharmacol pmid:3043436
Evans TW et al. Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man. 1988 Br. J. Pharmacol. pmid:3401633
Lagente V et al. Interference of the Paf antagonist Ro 19-3704 with Paf and antigen-induced bronchoconstriction in the guinea-pig. 1988 Br. J. Pharmacol. pmid:3401641
Groscurth P et al. Effects of platelet activating factor (PAF) on human citrated whole blood. 1988 Eur. J. Haematol. pmid:3402585
Rylander R et al. Modulation of pulmonary inflammation after endotoxin inhalation with a platelet-activating factor antagonist (48740 RP). 1988 Int. Arch. Allergy Appl. Immunol. pmid:3403044
Satoh K et al. [Endothelial injury as an initiating factor: vascular endothelial cell injury and biosynthesis of PAF]. 1988 Nippon Rinsho pmid:3404682
Nogami M et al. [Effects of a PAF antagonist CV-3988 on the acute gastric erosions of rats by water-immersion stress]. 1988 Nihon Shokakibyo Gakkai Zasshi pmid:3404759
Tamura N et al. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation. 1988 J. Immunol. pmid:2848892
Biologically active ether lipids. 1988 Prog Biochem Pharmacol pmid:3405995
Pretolani M et al. Active immunization induces lung hyperresponsiveness in the guinea pig. Pharmacologic modulation and triggering role of the booster injection. 1988 Am. Rev. Respir. Dis. pmid:3202509
Willuweit B and Aktories K Heparin and heparinoids impair adrenaline and platelet-activating factor but not thrombin-induced inhibition of adenylate cyclase and stimulation of GTP hydrolysis in human platelet membranes. 1988 Naunyn Schmiedebergs Arch. Pharmacol. pmid:2969081
Jancar S et al. Immune complex induced pancreatitis: effect of BN 52021, a selective antagonist of platelet-activating factor. 1988 Prostaglandins pmid:2969600
Tkhostov EB et al. [Calcium metabolism in arterial hypertension. I. Myocardial hypertrophy and hormone-dependent increase in Ca2+ levels in the thrombocytes of patients with arterial hypertension]. 1988 Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR pmid:2969736
Leprevost C et al. Inhibition of eosinophil chemotaxis by a new antiallergic compound (cetirizine). 1988 Int. Arch. Allergy Appl. Immunol. pmid:2971624
Ohmori K et al. Antiinflammatory and antiallergic effects of a novel metabolite of Nocardiopsis sp. as a potent protein kinase C inhibitor from microbial origin. 1988 Arzneimittelforschung pmid:2972291
Masugi F et al. Platelet-activating factor and anti-platelet-aggregating factor in acute reduction of blood pressure following percutaneous transluminal renal angioplasty in patients with renovascular hypertension. 1988 J Hum Hypertens pmid:2977405
Valone FH et al. Enhanced human monocyte cytotoxicity by platelet-activating factor. 1988 Immunology pmid:3169845
Popovich KJ et al. Role of platelets in contraction of canine tracheal muscle elicited by PAF in vitro. 1988 J. Appl. Physiol. pmid:3170437
Moriyama T et al. Elevation of cytosolic free Ca2+ is directly evoked by thromboxane A2 in human platelets during activation with collagen. 1988 J. Biochem. pmid:3170519
Lagente V et al. PAF-acether and endotoxin display similar effects on rat mesenteric microvessels: inhibition by specific antagonists. 1988 J. Pharmacol. Exp. Ther. pmid:3171975
Danko G et al. Effect of the PAF antagonists, CV-3988 and L-652,731 on the pulmonary and hematological responses to guinea pig anaphylaxis. 1988 Pharmacol Res Commun pmid:3174804
Bussolino F et al. Platelet activating factor induces dopamine release in PC-12 cell line. 1988 Am. J. Physiol. pmid:3177629
Hill CE et al. Location of platelet activating factor binding in rat liver. 1988 Biochem. J. pmid:3178735
Wichrowski B et al. Structure-activity relationship in PAF-acether. 4. Synthesis and biological activities of carboxylate isosteres. 1988 J. Med. Chem. pmid:3339611
Tilley JW et al. Pyrido[2,1-b]quinazolinecarboxamide derivatives as platelet activating factor antagonists. 1988 J. Med. Chem. pmid:3339617
Ferguson MK et al. Lymphatic smooth muscle responses to leukotrienes, histamine and platelet activating factor. 1988 J. Surg. Res. pmid:3339877
Kelefiotis D et al. Study of digoxin as inhibitor of the in vivo effects of acetyl glyceryl ether phosphorylcholine (AGEPC) in mice. 1988 Life Sci. pmid:3339951
Soybel DI et al. Effects of platelet-activating factor on canine gastric mucosal blood flow and permeability to luminal acid. 1988 Am. J. Surg. pmid:3341532
Kumar R et al. Occurrence of platelet-activating factor in rabbit spermatozoa. 1988 Arch. Biochem. Biophys. pmid:3341753
Huo YN et al. A preferential inhibition by Zn2+ on platelet activating factor- and thrombin-induced serotonin secretion from washed rabbit platelets. 1988 Arch. Biochem. Biophys. pmid:3341767
Brass LF et al. Interactions in platelets between G proteins and the agonists that stimulate phospholipase C and inhibit adenylyl cyclase. 1988 J. Biol. Chem. pmid:2833506
Blank ML et al. Stimulation of the de novo pathway for the biosynthesis of platelet-activating factor (PAF) via cytidylyltransferase activation in cells with minimal endogenous PAF production. 1988 J. Biol. Chem. pmid:2833508
Rola-Pleszczynski M et al. Immune regulation by platelet-activating factor. I. Induction of suppressor cell activity in human monocytes and CD8+ T cells and of helper cell activity in CD4+ T cells. 1988 J. Immunol. pmid:2834440
Worthen GS et al. The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor. Potential role in mediation of enhanced superoxide secretion. 1988 J. Immunol. pmid:2834441
Touvay C et al. Role of platelet-activating factor (PAF) in the bronchopulmonary alterations and beta-adrenoceptor function induced by endotoxin. 1988 Biochem. Biophys. Res. Commun. pmid:2835036
Hofmann B et al. Effect of specific antagonists on PAF-induced platelet aggregation and release of plasminogen activator. 1988 Biomed. Biochim. Acta pmid:3248103
17th annual UCLA symposium. Abstracts: Cell activation and signal initiation: receptor and phospholipase control of inositol phosphate, PAF and eicosanoid production. 1988 J. Cell. Biochem. Suppl. pmid:2835556
Mest HJ et al. The arrhythmogenic effect of platelet activating factor (PAF) is inhibited by PAF antagonist and by substances influencing eicosanoids. 1988 Biomed. Biochim. Acta pmid:3248107
Wainwright CL et al. The effects of PAF antagonists on ischaemia and reperfusion arrhythmias and ischaemia-induced platelet aggregation. 1988 Biomed. Biochim. Acta pmid:3248108
Dembińska-Kieć A et al. Release of cysteinyl-leukotrienes is of minor importance in PAF induced reduction of perfusion rate in the gastric vascular bed. 1988 Biomed. Biochim. Acta pmid:3248109
Ostermann G et al. Structure-activity relationships of synthetic analogues of platelet-activating factor. 1988 Biomed. Biochim. Acta pmid:3248110
Droy-Lefaix MT et al. The amplificative role of PAF-acether in the oxidative stress following reperfusion of ischemic stomach. 1988 Basic Life Sci. pmid:3250539
Leslie CC et al. Properties and purification of an arachidonoyl-hydrolyzing phospholipase A2 from a macrophage cell line, RAW 264.7. 1988 Biochim. Biophys. Acta pmid:3143418
Egger M et al. Human platelet electrorotation change induced by activation: inducer specificity and correlation to serotonin release. 1988 Biochim. Biophys. Acta pmid:3143424
Pitcock JA Morphometric studies of the renomedullary interstitial cells. 1988 Am. J. Med. Sci. pmid:3284348
Hwang SB et al. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor. 1988 J. Pharmacol. Exp. Ther. pmid:2841449
Parnham MJ PAF receptors. 1988 Prog Biochem Pharmacol pmid:2841664
Shkhvatsabaia IK et al. [Receptor-dependent regulation of the concentration of Ca2+ in the cytoplasm of thrombocytes in hypertensive patients]. 1988 Kardiologiia pmid:2842537
Tahraoui L et al. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation. 1988 Mol. Pharmacol. pmid:2842653
Garcia JG et al. Effect of platelet activating factor on leukocyte-endothelial cell interactions. 1988 Thromb. Res. pmid:2842887
Ng DS and Wong K Specific binding of platelet-activating factor (PAF) by human peripheral blood mononuclear leukocytes. 1988 Biochem. Biophys. Res. Commun. pmid:2843182
Browne PC et al. Kinetics of the formation of thrombin-thrombospondin complexes: involvement of a 77-kDa intermediate. 1988 Arch. Biochem. Biophys. pmid:2844122
Yamada K et al. Highly sensitive gas chromatographic--mass spectrometric method for the determination of platelet-activating factor in human blood. 1988 J. Chromatogr. pmid:3235552
Birkle DL et al. Platelet-activating factor antagonist BN52021 decreases accumulation of free polyunsaturated fatty acid in mouse brain during ischemia and electroconvulsive shock. 1988 J. Neurochem. pmid:2846788
Yoshikawa D and Goto F [Interactions between platelet activating factor and leukotrienes during endotoxin shock in the rat]. 1988 Masui pmid:3236398
Wykle RL et al. Platelet-activating factor. 1988 Meth. Enzymol. pmid:3237085
Rouis M et al. Platelet activating factor is a potent stimulant of the production of active oxygen species by human monocyte-derived macrophages. 1988 Biochem. Biophys. Res. Commun. pmid:2847729
Kioumis I et al. Effect of inhaled platelet-activating factor on circulating neutrophils and platelets in vivo and ex vivo in man. 1988 Prostaglandins pmid:3237997
Doni MG et al. Forskolin and prostacyclin inhibit fluoride induced platelet activation and protein kinase C dependent responses. 1988 Biochem. Biophys. Res. Commun. pmid:2847730
Sirois MG et al. PAF increases vascular permeability in selected tissues: effect of BN-52021 and L-655,240. 1988 Prostaglandins pmid:3238010
Schindler PW et al. Fluorophore-labeled ether lipids: substrates for enzymes of the platelet-activating factor cycle in peritoneal polymorphonuclear leukocytes. 1988 Anal. Biochem. pmid:3239750
Silva PM et al. Adrenalectomy exacerbates paw edema without interfering with desensitization induced by PAF-acether in rats. 1988 Braz. J. Med. Biol. Res. pmid:3240383
Ghigo D et al. Role of Na+/H+ exchange in thrombin-induced platelet-activating factor production by human endothelial cells. 1988 J. Biol. Chem. pmid:2848827
Aratani H et al. Effect of etizolam (Depas) on production of superoxide anion by platelet-activating factor and N-formyl-methionyl-leucyl-phenylalanine-stimulated guinea pig polymorphonuclear leukocytes. 1988 Jpn. J. Pharmacol. pmid:2848961
Robertson DN et al. The effect of platelet-activating factor on histamine and muscarinic receptor function in guinea pig airways. 1988 Am. Rev. Respir. Dis. pmid:2849329
Stewart AG and Dusting GJ Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages. 1988 Br. J. Pharmacol. pmid:2850058